<DOC>
	<DOCNO>NCT03093935</DOCNO>
	<brief_summary>StimRouter Neuromodulation System include implanted lead provide peripheral nerve stimulation chronic pain . Post-stroke shoulder pain patient focus study . After meet inclusion/exclusion criterion , approximately 50 enrol patient participate study 6 month follow-up . Various measure use assess patient response use device .</brief_summary>
	<brief_title>StimRouter™ Pain Management Post-stroke Shoulder Pain</brief_title>
	<detailed_description>Adults age 18 severe intractable chronic shoulder pain subsequent stroke include . Pain relief measure use StimRouter stimulation therapy target axillary nerve . Existing/pre-study pain medication must either maintain , reduce throughout trial . Study Design prospective , multi-center include 50 subject The primary endpoint clinically relevant pain reduction ( 30 % ) pain score 3 month initiate stimulation least 50 % patient increase pain medication . Primary Outcomes : Reduction average pain rest measure numeric scale ( BPI-SF5 ) Secondary Outcomes 1 . Change Worst Pain ( BPI-SF3 ) 2 . Least Pain &amp; Pain Right Now ( BPI - SF 4,6 ) 3 . Patient Global Impression Change ( PGIC ) 4 . Patient Satisfaction questionnaire 5 . Shoulder Q Data Collection Points 1 ) Baseline 2 ) Month 1 post-programming 3 ) Month 2 post-programming 4 ) Month 3 post-programming 5 ) Month 6 post-programming Data Analysis Analyses make evaluate difference outcomes compare baseline measure , primary endpoint Month 3 - Standard statistical estimation inference undertaken observed treatment effect . - All adverse event tabulate frequency proportion .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Shoulder Pain</mesh_term>
	<criteria>Male female age ≥18 year confirm diagnosis stroke Competent provide consent comply study requirement Minimum 3 month severe chronic focal poststroke shoulder pain Stable regimen pain medication &gt; 4 week prior implant willing maintain equivalent dosage throughout study A mean score &gt; 4 Brief Pain Inventory short form , question 3 ( BPISF3 ) Capable willing follow studyrelated procedure Able tolerate surface stimulation demonstrate motor level response shoulder Patients decline provide write consent attend followup visit Shoulder pathology ( e.g . rotator cuff tear , frozen shoulder etc ) target limb Evidence primary central regional pain pattern inclusive shoulder Diagnosed/confirmed shoulder dysfunction Botox neurolytic agent injection last 3 month Any confound neurologic condition affect upper limb Evidence history skin infection History adverse reaction local anesthetic ( e.g . lidocaine ) adhesives Patients active systemic infection immunocompromised Patients pregnant , intend become pregnant , breastfeed childbearing potential practicing medicallyapproved method birth control Currently require likely require Magnetic Resonance Imaging ( MRI ) within MRI exclusion zone define within 50cm isocenter 16 cm MR coil measure edge MRI coil . Any metallic implant immediate area intend implant ( e.g . TSR ) Has demandtype cardiac pacemaker , defibrillator , electrical nerve implant Potential need diathermy implant site Potential need therapeutic ultrasound implant site Patients already implant StimRouter TM prior study enrollment Presence document condition abnormality could compromise safety patient Life expectancy less 1 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Post-Stroke</keyword>
	<keyword>Neuromodulation</keyword>
	<keyword>Axillary nerve</keyword>
	<keyword>Peripheral Nerve Stimulation</keyword>
</DOC>